Figure 4. Fasting Plasma Glucose (FPG) Level and Body Weight Efficacy Parameters From Baseline to Week 26 Among Patients With Type 2 Diabetes and Insufficient Glycemic Control.

RMM indicates repeated measures model; SC, subcutaneous. Data are estimated means from the RMM with treatment, stratum, country, and baseline value all nested within visit. Error bars are 95% CIs.

^aNo. of patients with an assessment.